TGFB1 and COVID-19: Altogether, these data indicate that untimely TGF-β secretion in certain COVID-19 patients leads to downregulation of T-bet and, consequently, integrin-ß2 expression on NK cells, preventing them from successfully binding to and killing infected cells that eventually leads to increased viral loads and disease severity (Fig. 1).